Entity > Corporation > US > New York City New York > Axsome Therapeutics
About Axsome Therapeutics
Industry: Business & Industrial > Pharmaceuticals & Biotech
More information about Axsome Therapeutics
| Company Attribute | Value |
| Name | Axsome Therapeutics |
| Url | axsome |
| Wikidata | wikidata |
Axsome Therapeutics
New York City, US
1 May 2024
Axsome Therapeutics
All
News
Images
Maps
Videos
More
Page: 1
Desktop | Laptop Devices
https://www.axsome.com/
Axsome Therapeutics is developing innovative treatments for CNS conditions. Get information on our current in-market medicines, pipeline, conditions and ...
Rich Sitelinks
People Also Ask
https://finance.yahoo.com › quote › AXSM
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the ...
https://www.globaldata.com › All Companies
Axsome Therapeutics Inc (Axsome) is a biopharmaceutical company that develops and commercializes therapies for the treatment of central nervous system (CNS) ...
https://www.marketwatch.com › ... › United States
AXSM | Complete Axsome Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
https://www.nasdaq.com › ... › Stocks › AXSM
Find the latest institutional holdings data for Axsome Therapeutics, Inc. Common Stock (AXSM) including shareholders, ownership summaries, ...
https://www.linkedin.com/company/axsome-therapeutics-inc-
Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have ...
https://www.reuters.com › healthcare-pharmaceuticals
1 month ago — Axsome Therapeutics said on Monday its experimental therapy cut the frequency of disruptive episodes of muscle weakness tied to a sleep ...
Related Searches
axsome therapeutics address
axsome therapeutics news
axsome therapeutics buyout
Knowledge Panel
Axsome Therapeutics (Pharma corporation)
Axsome Therapeutics, Inc. is a biopharmaceutical company developing and delivering novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions.
-
Stock price : AXSM (NASDAQ) $73.76 +0.07 (+0.09%)Apr 30, 4:00 PM EDT - Disclaimer
-
CEO : Herriot Tabuteau (Jan 2012–)
-
Headquarters : United States
-
Founded : 2012
| Entity Home | Kalicube Pro Entity Page |